MarketCap
Facebook
X
TelegramGeschäftsbericht 2022
hinzugefügt 29.03.2023
Chembio Diagnostics Anteile 2011-2026 | CEMI
Anteile Jährlich Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 32.3 M | 24.3 M | 20.1 M | 17 M | 14.4 M | 12.3 M | 10.6 M | 9.63 M | 9.53 M | 8.99 M | 7.99 M | 7.87 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 32.3 M | 7.87 M | 14.6 M |
Anteile Vierteljährlich Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 32.3 M | - | 30.1 M | 30.1 M | 26.7 M | 20.2 M | 20.2 M | 20.2 M | 20.1 M | 18.9 M | 17.2 M | 17.7 M | 16.9 M | 16.9 M | 17.2 M | 17.2 M | 14.2 M | 14.2 M | 13.3 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 12 M | 11.1 M | 9.67 M | 9.63 M | 9.63 M | 9.63 M | 9.63 M | 9.62 M | 9.61 M | 9.61 M | 9.56 M | 9.34 M | 9.32 M | 9.32 M | 9.26 M | 8.06 M | 8.04 M | 8 M | 7.99 M | 7.93 M | 7.92 M | 7.91 M | 7.88 M | 62.3 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 62.3 M | 7.88 M | 14.9 M |
Anteile anderer Aktien in der Diagnostik & Forschung
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
BioNano Genomics
BNGO
|
5.44 M | $ 1.13 | - | $ 6.15 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 16.07 | -0.28 % | $ 173 M |  China |
 |
Agilent Technologies
A
|
304 M | $ 115.27 | 0.17 % | $ 35 B | USA |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 16.35 | 1.87 % | $ 871 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 2.25 | -2.17 % | $ 9.95 M | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 1.38 | 0.91 % | $ 1.84 M | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 23.14 | 0.04 % | $ 643 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 176.98 | 0.74 % | $ 8.77 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 496.91 | 0.68 % | $ 14.3 B | USA |
 |
Danaher Corporation
DHR
|
713 M | $ 191.04 | 0.78 % | $ 136 B | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.45 | 2.18 % | $ 412 M | USA |
 |
Illumina
ILMN
|
159 M | $ 122.89 | 1.62 % | $ 19.5 B | USA |
 |
NeoGenomics
NEO
|
128 M | $ 7.9 | 2.67 % | $ 1.01 B | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 14.96 | 3.64 % | $ 452 M | USA |
 |
Guardant Health
GH
|
125 M | $ 79.03 | 0.54 % | $ 9.91 B | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
32.5 K | $ 2.76 | 2.6 % | $ 89.6 K | USA |
 |
Biomerica
BMRA
|
2.3 M | $ 2.07 | -3.27 % | $ 4.75 M | USA |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
904 M | $ 28.14 | -0.58 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 107.18 | 0.35 % | $ 8.84 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 260.85 | -0.03 % | $ 21.7 B | USA |
 |
Natera
NTRA
|
98.4 M | $ 197.77 | 2.46 % | $ 19.5 B | USA |
 |
Celcuity
CELC
|
46.8 M | $ 118.02 | 0.75 % | $ 5.52 B | USA |
 |
Senseonics Holdings
SENS
|
41.7 M | $ 6.61 | -1.05 % | $ 276 M | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 80.46 | -0.17 % | $ 5.43 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 190.61 | -0.48 % | $ 21.2 B | USA |
 |
Soleno Therapeutics
SLNO
|
50.8 M | $ 52.6 | -0.06 % | $ 2.67 B | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.09 | -3.56 % | $ 1.97 B | USA |
 |
ENDRA Life Sciences
NDRA
|
787 K | $ 5.0 | 1.21 % | $ 3.94 M | USA |
 |
Organovo Holdings
ONVO
|
1.46 M | - | -2.3 % | $ 19.4 M | USA |